Petrisor Brad A, Poolman Rudolf, Koval Kenneth, Tornetta Paul, Bhandari Mohit
Department of Surgery, McMaster University, Hamilton Health Sciences-General Hospital, Hamilton, Ontario, Canada.
J Orthop Trauma. 2006 Jul;20(7):515-8. doi: 10.1097/00005131-200608000-00012.
Ankle fractures excluding pilon fractures, account for approximately 9% of all fractures with the majority being OTA type B injuries. Although surgeons generally treat undisplaced or minimally displaced injuries nonoperatively and displaced fractures operatively, opinions diverge regarding the management of those displaced fractures with acceptable closed reduction. There is also debate about the use of biodegradable implants in operatively managed ankle fractures, the type and technique of fixation for operatively treated syndesmotic injuries as well as the approach to postoperative rehabilitation.
We aimed to review the highest level of available evidence on the operative management of ankle fractures. We focused specifically on studies comparing (1) nonoperative versus operative management of displaced ankle fractures, (2) biodegradable versus metal implants, (3) syndesmotic fixation, and (4) postoperative rehabilitation protocols.
不包括pilon骨折的踝关节骨折约占所有骨折的9%,其中大多数为OTA B型损伤。尽管外科医生通常对无移位或轻微移位的损伤采取非手术治疗,对移位骨折采取手术治疗,但对于那些可接受闭合复位的移位骨折的处理,意见存在分歧。关于在手术治疗的踝关节骨折中使用可生物降解植入物、手术治疗下胫腓联合损伤的固定类型和技术以及术后康复方法也存在争议。
我们旨在回顾踝关节骨折手术治疗的现有最高水平证据。我们特别关注比较以下方面的研究:(1)移位踝关节骨折的非手术与手术治疗;(2)可生物降解与金属植入物;(3)下胫腓联合固定;(4)术后康复方案。